Lumexa Imaging Holdings, Inc. Common Stock Market Cap ($1.08 Billion)
Market Cap & Net Worth: Lumexa Imaging Holdings, Inc. Common Stock (LMRI)
Lumexa Imaging Holdings, Inc. Common Stock market cap. Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ:LMRI) has a market capitalization of $1.08 Billion ($1.08 Billion) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #8224 globally and #2443 in its home market, demonstrating a 4.78% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lumexa Imaging Holdings, Inc. Common Stock's stock price $11.41 by its total outstanding shares 96074976 (96.07 Million). Also see how efficiently does Lumexa Imaging Holdings, Inc. Common Sto generate cash for how efficiently the company converts equity into cash flow.
Lumexa Imaging Holdings, Inc. Common Stock Market Cap History (2025–2026)
Lumexa Imaging Holdings, Inc. Common Stock market cap history from 2025 to 2026. Data shows growth from $1.78 Billion to $1.10 Billion (0.00% CAGR). Check today's stock price for Lumexa Imaging Holdings, Inc. Common Sto for real-time trading data and today's change.
Lumexa Imaging Holdings, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lumexa Imaging Holdings, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Lumexa Imaging Holdings, Inc. Common Sto (LMRI) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.74x
Lumexa Imaging Holdings, Inc. Common Stock's market cap is 1.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $1.78 Billion | $1.02 Billion | -$47.10 Million | 1.74x | N/A |
Competitor Companies of LMRI by Market Capitalization
Companies near Lumexa Imaging Holdings, Inc. Common Stock in the global market cap rankings as of November 1, 2026. Also see Lumexa Imaging Holdings, Inc. Common Sto balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Lumexa Imaging Holdings, Inc. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Lumexa Imaging Holdings, Inc. Common Stock (2025–2026)
Market capitalization of Lumexa Imaging Holdings, Inc. Common Stock from 2025 to today. Between 2025 and today, Lumexa Imaging Holdings, Inc. Common Stock's market cap moved from $1.78 Billion to $ 1.10 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.10 Billion | -38.32% |
| 2025 | $1.78 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Lumexa Imaging Holdings, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.08 Billion USD |
| MoneyControl | $1.08 Billion USD |
| MarketWatch | $1.08 Billion USD |
| marketcap.company | $1.08 Billion USD |
| Reuters | $1.08 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was foun… Read more